Epilepsy and neurodegenerative diseases in adults: A clinical review

Epileptic Disorders

Volumn 8, Issue SUPPL. 1, 2006, Pages

  Vercueil, Laurent ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Alzheimer; Dementia; Epilepsy; Neurodegenerative disorders

Indexed keywords

ANTICONVULSIVE AGENT;

ALZHEIMER DISEASE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE ASSOCIATION; DOWN SYNDROME; EPILEPSY; HEALTH CARE; HIPPOCAMPAL SCLEROSIS; HUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 33745845144     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Ala TA, Beh GO, Frey II WH. Pure hippocampal sclerosis. A rare cause of dementia mimicking Alzheimer's disease. Neurology 2000; 54: 843-8.
2. Amemiya S, Hamamoto M, Goto Y, et al. Psychosis and progressive dementia: presenting features of a mitochondriopathy. Neurology 2000; 55: 600-1.
3. Anonymous. Special groups of patients. Epilepsy in the elderly. Epilepsia 2003; 44(Suppl.6): 77-8.
4. Armon C, Peterson GW, Liwnicz BH. Alzheimer's disease underlies some cases of complex partial status epilepticus. J Clin Neurophysiol 2000; 17: 511-8.
5. Au WJ, Gabor AJ, Vijayan N, Markand ON. Periodic lateralized epileptiform complexes in Creutzfeldt-Jakob disease. Neurology 1980; 30: 611-7.
6. Axelman K, Basun H, Lannfelt L. Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Arch Neurol 1998; 55: 698-702.
7. Bakchine S, Lacomblez L, Pallisson E, Laurent M, Derouesné C. Relationship between primitive reflexes, extrapyramidal signs, reflective apraxia and severity of cognitive impairment in dementia of the Alzheimer type. Acta Neurol Scand 1989; 79: 38-46.
8. Bengel D, Supprian T, Lesch KP. Koinzidenz von Chorea Huntington und Epilepsie. Nervenartz 1997; 68: 270-3.
9. Berkovic SF, Carpenter S, Anderman F, et al. Kufs' disease: a critical reappraisal. Brain 1988; 111: 27-62.
10. Bodenmann P, Ghika J, van Melle G, Bogousslavsky J. Comorbidités neurologiques du parkinsonisme. Rev Neurol (Paris) 2001; 157: 45-54.
11. Brodie MJ, Overstall PW, Giorgi L, et al. Multi-centre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37: 81 -7.
12. Brown P, Cathala F, Castaigne P, Gajdusek DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 1986; 20: 597-602.
13. Canafoglia L, Franceschetti S, Antozzi C, et al. Epileptic phenotypes associated with mitochondrial disorders. Neurology 2001; 56: 1340-6.
14. Caviness JN. Myoclonus and neurodegenerative disease - what's in a name? Park Rel Disord 2003; 9: 185-92.
15. Chandra V, Bharucha NE, Schoenberg BS. Conditions associated with Alzheimer's disease at death: case-control study. Neurology 1987; 36: 209-11.
16. Chiofalo N, Fuentes A, Galvez S. Serial EEG findings in 27 cases of Creutzfeldt-Jakob. Arch Neurol 1980; 37: 143-5.
17. Corey-Bloom J, Sabbagh MN, Bondi MW, et al. Hippocampal sclerosis contributes to dementia in the elderly. Neurology 1997; 48: 154-60.
18. Crook R, Ellis R, Shanks M, et al. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German persenilin-2 mutation. Ann Neurol 1997; 42: 124-8.
19. Dananchet Y, Monavon A, Kahane P, Besson G, Garrel S. Etat de mal frontal révélateur d'une maladie de Creutzfeldt-Jakob familiale. Epilepsies 2001; 13: 273.
20. Daniel SE, De Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995; 118: 759-70.
21. De Angelis G, Vizoli R. Maladie de Parkinson et épilepsie: hypothèse d'une incompatibilité biologique. Rev Neurol (Paris) 1984; 140: 440-2.
22. De Michele G, Maltecca F, Carella M, et al. Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum of two Italian families with spinocerebellar ataxia type 17. Neurol Sci 2003; 24: 166-7.
23. Dening TR, Berrios GE, Walshe JM. Wilson's disease and epilepsy. Brain 1988; 111: 1139-55.
24. Ettinger AR, Devinsky O. Managing epilepsy and co-existing disorders. Butterwoth-Heinemann, 2002.
25. Ezquerra M, Carnero C, Blesa R, Gelpi JL, Ballesta F, Oliva R. A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures. Neurology 1999; 52: 566-70.
26. Fernandez-Torre JL, Solar DM, Astudillo A, Cereceda R, Acebes A, Catalayud MT. Creutzfeldt-Jakob disease and nonconvulsive status epilepticus: a clinical and electroencephalographic follow-up study. Clin Neurophysiol 2004; 115: 316-9.
27. Filla A, De Michele G, Cocozza S, et al. Early-onset autosomal dominant dementia with ataxia, extrapyramidal features, and epilepsy. Neurology 2002; 58: 922-8.
28. Förstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P. Neurologic signs in Alzheimer's disease. Result of a prospective clinical and neuropathological study. Arch Neurol 1992; 49: 1038-42.
29. Foster NL, Wilhelmsen KC, Sima AAF, Jones MZ, D'Amato CJ, Gilman S. Conference participants. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997; 41: 706-15.
30. Fox NC, Kennedy AM, Harvey RJ, et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Brain 1997; 120: 491-501.
31. Fu C, Chute DJ, Farag ES, Garakian J, Cummings JL, Vinters HV. Comorbidity in dementia. An autopsy study. Arch Pathol Lab Med 2004; 128: 32-8.
32. Gaitatzis A, Carroll K, Majeed A. W Sander J. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004; 45: 1613-22.
33. Garrel S, Joannard A, Feuerstein J, Serre F. Formes myocloniques de la chorée de Huntington. Rev EEG Neurophysiol 1978; 8: 123-8.
34. Genton P, Malafosse A, Moulard B, et al. Progressive myoclonus epilepsies. Eastleigh: John Libbey & co Ltd, 2002.
35. Genton P, Paglia G. Epilepsie myoclonique sénile? myoclonies épileptiques d'apparition tardive dans un syndrome de Down. Epilepsies 1994; 6: 5-11.
36. Granger N, Convers P, Beauchet O, et al. Première crise d'épilepsie chez le sujet de plus de 60 ans: données électrocliniques et écologiques. Rev Neurol (Paris) 2002; 158: 1088-95.
37. Growdon JH, Rossor M. The Dementias. Blue Books of Practical Neurology. Butterworth & Heinemann, 1998.
38. Hallett M, Wilkins DE. Myoclonus in Alzheimer's disease and minipolymyoclonus. Adv Neurol 1986; 43: 399-405.
39. Harvey RJ, Ellison D, Hardy H, et al. Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine to serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry 1998; 64: 44-9.
40. Hauser WA, Annegers J, Kurland L. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1991; 34: 453-68.
41. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986; 36: 1226-30.
42. Henneberg AE, Schöll I, Kogan E. Myoclonic astatic attacks in patients suffering from Parkinson's disease. Eur J Neurol 1998; 5: 365-8.
43. Hersdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology 1996; 46: 727-30.
44. Hodges JR, Miller B. The classification, genetics and neuropathology of frontotemporal dementia Introduction to the special topic papers: Part I. Neurocase 2001; 7: 31-5.
45. Hogh P, Smith SJ, Scahill RI, et al. Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment. Neurology 2002; 58: 298-301.
46. Jimenez-Jimenez FJ, Molina-Arjona JA, Roldan-Montau A, Fernandez-Ballesteros A, Zancada F, Santos J. Maladie de Parkinson et ëpilepsie. Rev Neurol (Paris) 1991; 147: 144-5.
47. Joseph KA, Tang Wai DF, Parisi JE. Hippocampal sclerosis in a case of Alzheimer's disease-like dementia with late onset intractable epilepsy. Eur J Neurol 2003; 10: 333-4.
48. Kowh HJ, Szecsey A, Vogel M. Sedation caused by primidone may exacerbate dementia. Epilepsy Behav 2003; 4: 592.
49. Lai F, Williams RS. A prospective study of Alzheimer's disease in Down syndrome. Arch Neurol 1989; 46: 849-53.
50. Lebenshon ZM, Jenkins RB. Improvement of Parkinsonism in depressed patients treated with ECR. Am J Psychiatry 1975; 132: 283-5.
51. Lee K, Haight E, Olejniczak P. Epilepsia partialis continua in Creutzfeldt-Jakob disease. Acta Neurol Scand 2000; 102: 398-402.
52. Leppik IE, Birnbaum A. Epilepsy in the elderly. Sem Neurol 2002; 22: 309-19.
53. Leverenz JB, Agustin CM, Tsuang D, et al. Clinical and neuropathological characteristics of hippocampal sclerosis: a community-based study. Arch Neurol 2002; 59: 1099-106.
54. Li LM, O'Donoghue MF, Sander JW. Myoclonic epilepsy of late onset in trisomy 21. Arq Neuropsiquiatr 1995; 53: 792-4.
55. Li S, Schoenberg BS, Wang C, et al. Epidemiology of epilepsy: urban areas of the People' Republica of China. Epilepsia 1985; 26: 391-4.
56. Loiseau J, Loiseau P, Duché B, Guyot M, Dartigues JF, Aublet B. A survey of epileptic disorders in Southwest France: seizures in elderly people. Ann Neurol 1990; 27: 232-7.
57. Lopera F, Ardilla A, Martinez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997; 277: 793-9.
58. Mahieux F. Sclérose de l'hippocampe et démences. Psychol Neuropsychiatr Vieillissement 2003; 1: 179-86.
59. Masnou P. Epilepsie du sujet âgé. Lett Neurol 2001; 5: 337-41.
60. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35: 453-61.
61. McAreavey MJ, Ballinger BR, Fenton GW. Epileptic seizures in elderly patients with dementia. Epilepsia 1992; 33: 657-60.
62. McCullagh CD, Craig S, McIlroy SP, Passmore AP. Risk factors for dementia. Adv Psychiatr Treat 2001; 7: 24-31.
63. McVicker RW, Shanks OE, McClelland RJ. Prevalence and associated features of epilepsy in adults with Down's syndrome. Br J Psychiatry 1994; 164: 528-32.
64. Meinardi H. Epilepsies (Part II. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology. Elsevier, 2000.
65. Melanson M, Nalbantogu J, Berkovic S, et al. Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease. Neurology 1997; 49: 1732-3.
66. Mendez MF, Catarzaro P, Doss RC, Arguello R, Frey II WH. Seizures in Alzheimer's disease: clinicopathologic study. J Geriatr Psychiatry Neurol 1994; 7: 230-3.
67. Mendez MF, Cummings JL. Dementia: a clinical approach. 3rd ed. Butterworth & Heinemann, 2003.
68. Miller BL. Clinical advances in degenerative dementias. Br J Psychiatr 1997; 171: 1-3.
69. Moellentine C, Rummans T, Alshkog JE, et al. Effectiveness of ECT in patients with parkinsonism. J Neuropsychiatry Clin Neurosci 1998; 10: 187-93.
70. Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure 2001; 10: 303-5.
71. Neufeld MY, Talianski-Aronov A, Soffer D, Korczyn AD. Generalized convulsive status epilepticus in Creutzfeldt-Jakob disease. Seizure 2003; 12: 403-5.
72. Nygaard TG, Duvoisin RC, Manocha M, Chokroverty S. Seizure in progressive supranuclear palsy. Neurology 1989; 39: 138-40.
73. Obeso JA, Artieda J, Tunon T, Luquin MR, Martinez Lage JM. Dopamine agonists suppress visual-cortical reflex myoclonus. J Neurol Neurosurg Psychiatry 1985; 48: 1277-83.
74. Parry J, Tuch P, Knezevic W, Fabian V. Creutzfeldt-Jakob syndrome presenting as epilepsia partialis continua. J Clin Neurosci 2001; 3: 266-8.
75. Pasquier F, Lebert F, Lavenu I, Petit H. Diagnostic clinique des démences fronto-temporales. Rev Neurol (Paris) 1998; 154: 217-23.
76. Peinemann A, Stefan H. Altersepilepsie. Nervenartz 1998; 69: 110-6.
77. Peset V, Castillo A, Brocalero A, Juni J, Sancho J. Epilepsia y demencia por cuerpos de Lewy. Rev Neurol 2001; 33: 895-6.
78. Poser S, Mollenhauer B, Krauss A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345-51.
79. Pridmore S, Yeo PT, Pasha MI. Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder. J Neurol Neurosurg Psychiatry 1995; 58: 641-2.
80. Pueschel SM, Louis S, McKnight P. Seizure disorders in Down syndrome. Arch Neurol 1991; 48: 318-20.
81. Rees JH, Smith SJ, Kullmam DM, Hirsch NP, Howard RP. Creutzfeldt-Jakob disease presenting as complex partial status epilepticus: a report of two cases. J Neurol Neurosurg Psychiatry 1999; 66: 406-7.
82. Richter RW, Richter BZ. Alzheimer's disease: a physician's guide to clinical management. Humana Press, 2004.
83. Rocchi A, Pellegrini S, Siciliano G, Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 2003; 61: 1-24.
84. Roger J, Bureau M, Dravet CH, Genton P, Tassinari CA. La place des encéphalopathies mitochondriales dans les epilepsiesmyocloniques progressives. Rev Neurol (Paris) 1991; 147: 480-90.
85. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990; 47: 847-50.
86. Rowan AJ. Epilepsy and the elderly. Epilepsy Behav 2000; 1(Suppl): S12-S14.
87. Scarpino O, Pelliccioni G, Guidi M, Mauro AM, Mercante O. Maladie de Parkinson et épilepsie photosensible. Rev Neurol (Paris) 1990; 146: 36-40.
88. Sillantini MG, Van Swieten JC, Goedert M. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2000; 2: 193-205.
89. Sinforiani E, Manni R, Bernasconi L, Banchieri LM, Zucchella C. Memory disturbances and temporal lobe epilepsy simulating Alzheimer's disease: a case report. Funct Neurol 2003; 18: 39-41.
90. Sirven JI. Acute and chronic seizures in patients older than 60 years. Mayo Clin Proc 2001; 76: 175-83.
91. Sperfeld AD, Collatz MB, Baier H, et al. FTDP-17: an early-onset phenotype with parkinsonsism and epileptic seizures caused by novel mutation. Ann Neurol 1999; 46: 708-15.
92. Stephen LJ, Brodie MJ. Epilepsy in elderly people. Lancet 2000; 355: 1441-6.
93. Tallis R, Boon P, Perucca E, Stephen L. Epilepsy in elderly people: management issues. Epileptic Disord 2002; 4(Suppl.2): S33-S39.
94. Thomas P, Arzimanoglou A. Epilepsies. 2e Ed. Paris: Masson, 2000.
95. Thomas RJ. Seizures and epilepsy in the elderly. Arch Intern Med 1997; 157: 605-17.
96. Trinka E. Epilepsy: comorbidity in the elderly. Acta Neurol Scand 2003; 108(Suppl.180): 33-6.
97. Tsiouris JA, Patti PP, Tipu O, Raguthu S. Adverse effects of phenytoin given for late-onset seizures in adults with Down syndrome. Neurology 2002; 59: 779-80.
98. Tsuji S. Dentatorubral-pallidolyusian atrophy (DRPLA). J Neural Transm Suppl 2000; 58: 167-80.
99. Tyrrell J, Cosgrave M, McCarron M, et al. Dementia in people with Down's syndrome. Int J Geriatr Psychiatr 2001; 16: 1168-74.
100. Urechia CI, Mihalescu S. Epilepsie et Parkinsonisme; examen anatomique. Rev Neurol (Paris) 1928: 99-101.
101. Van Cott AC. Epilepsy and EEG in the elderly. Epilepsia 2002; 43(Suppl.3): 94-102.
102. Van Duijn CM. Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychatry 1996; 60: 478-88.
103. Vercueil L, Hirsch E. Seizures and the basal ganglia: a review of the clinical data. Epileptic Disord 2002; 4(Suppl3): S47-S54.
104. Vercueil L, Krieger J. Myoclonies de l'adulte: approche diagnostique. Neurophysiol Clin 2001; 31: 3-17.
105. Vercueil L. Parkinsonism and epilepsy: case report and reappraisal of an old question. Epilepsy Behav 2000; 1: 128-30.
106. Volicer L, Smith S, Volicer BJ. Effect of seizures on progression of dementia of the Alzheimer type. Dementia 1995; 6: 258-63.
107. Walstra GJ, Teunisse S, van Gool WA, van Crevel H. Reversible dementia in elderly patients referred to a memory clinic. J Neurol 1997; 244: 17-22.
108. Wilhelmsen KC, Lunch T, Pavlou E, Higgins M, Nygaard TG. Localisation of disinhibition-dementia-parkinsonism a myotrophy complex to 17q21-22. Am J Hum Genet 1994; 55: 1159-65.
109. Wilkins DE, Hallett M, Erba G. Primary generalised epileptic myoclonus: a frequent manifestation of minipolymyoclonus of cortical origine. J Neurol Neurosurg Psychiatry 1985; 48: 506-16.
110. Williams A. Defining neurodegenerative diseases. BMJ 2002; 324: 1465-6.
111. Wisniewski KE, Zhong N, Philippart M. Pheno/Genotypic correlations of neuronal ceroid lipofuscinosis. Neurology 2001; 57: 576-81.
112. Wyllie E. The treatment of epilepsy: principles and practice. Philadelphia: Lippincott, Williams & Wilkins, 2001.
113. Yakovlev P. Epilepsy and Parkinsonism. N Engl J Med 1928; 198: 629-38.
114. Yazaki M, Liepnieks JJ, Murrell JR, et al. Biochemical characterization of a neuroserpin variant associated with hereditary dementia. Am J Pathol 2001; 158: 227-33.
115. Zekry D, Hauw J-J, Gold G. Mixed dementia: epidemiology, diagnosis and treatment. J Am Geriatr Soc 2002; 50: 1431-8.